| Customization: | Available |
|---|---|
| CAS No.: | Customization, Customization |
| Formula: | Customization, Customization |
|
Still deciding? Get samples of $ !
Order Sample
|
| Shipping Cost: | Contact the supplier about freight and estimated delivery time. |
|---|
| Payment Methods: |
|
|---|---|
| Support payments in USD |
| Secure payments: | Every payment you make on Made-in-China.com is protected by the platform. |
|---|
| Refund policy: | Claim a refund if your order doesn't ship, is missing, or arrives with product issues. |
|---|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Introduction:
Halofuginone Hydrobromide is a derivative of a natural compound called febrifugine, which is derived from the Chinese herb Dichroa febrifuga. It was discovered for its potent antiparasitic properties, particularly against certain species of protozoa and nematodes. Since its discovery, Halofuginone Hydrobromide has gained significant interest in various fields of research and medical applications.
Function:
Halofuginone Hydrobromide exerts its function by inhibiting the synthesis of collagen, a crucial component of the extracellular matrix. It specifically targets the enzyme called "prolyl-tRNA synthetase," which is responsible for the production of collagen type I. By inhibiting this enzyme, Halofuginone Hydrobromide disrupts the balance between collagen synthesis and degradation, leading to the modulation of various biological processes, including fibrosis, inflammation, and proliferation of certain cell types.
Application:
Antiparasitic activity: Halofuginone Hydrobromide has been extensively studied for its potent antiparasitic effects against several protozoan parasites, including Plasmodium, Toxoplasma, and Cryptosporidium. It inhibits the growth and development of these parasites and shows promise as a potential therapeutic agent.
Antifibrotic activity: Fibrosis is a pathological condition characterized by excessive deposition of collagen and extracellular matrix components. Halofuginone Hydrobromide has shown promise in attenuating fibrosis in various organs, such as the liver, kidney, and lung. It can potentially be used to treat fibrotic diseases and prevent organ damage.
1. Are you a manufacturer or trading company?
A: We are a manufacturer and welcome to visit our factory.
){kind=link}